The investigators created a cohort of patients with juvenile inflammatory rheumatisms with the purpose to follow them prospectively, and investigate the tolerance and efficacy of immunosuppresive and biological agents.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of severe and very severe adverse event as a mesure of safety and tolerability
Timeframe: 10 years
Number of treatments prescribed off label
Timeframe: 10 Years
Length in months of drug survival in patient treated with at least two consecutive biological agents
Timeframe: 10 Years